Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
The summary for the Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44): This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $10 to $50 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. It is anticipated that emerging technologies are sufficiently advanced that, with additional investment, it may be possible to achieve proof of principle or even early stage commercialization of multiple different approaches for genome-scale sequencing within five years.
|Federal Grant Title:||Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HG-06-002|
|Type of Funding:||Grant|
|CFDA Descriptions:||Human Genome Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Feb 17, 2006|
|Posted Date:||Dec 15, 2005|
|Creation Date:||Dec 15, 2005|
|Archive Date:||Mar 19, 2006|
|Total Program Funding:||$1,500,000|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award for both Phase I and Phase II SBIR awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's Government Contracting Area Office or Office of Size Standards.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH
- Similar Government Grants
- • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers...
- • NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects...
- • International Bioethics Research Training Program (D43)
- • Centers of Excellence in Genomic Science (CEGS) (RM1)
- • Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - STTR (R41/R42)
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)